跳至主要内容
临床试验/ISRCTN14718882
ISRCTN14718882已完成未知

Intramuscular oxytocin versus intravenous oxytocin to prevent haemorrhage at vaginal delivery - A randomised controlled trial

Coombe Women and Infants University Hospital0 个研究点目标入组 1,000 人开始时间: 2016年1月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,000

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Aged 18 or over
  • 2. Female participants only
  • 3. Singleton pregnancy at more than 36 weeks gestation
  • 4. Those anticipated to have a vaginal delivery

排除标准

  • 1. Women who opted for physiological management of the third stage of labour
  • 2. Those who have an antenatal decision for 40IU oxytocin infusion prophylactically following a vaginal delivery
  • 3. Those whom the clinician has a preferred route of administering prophylactic oxytocin for the third stage of labour
  • 4. Those who are deemed to be at risk of postpartum haemorrhage - Previous history of atonic primary postpartum haemorrhage, multiple fibroids, coagulation disorders, thrombocytopenia and receiving anticoagulants
  • 5. Those with previous cardiovascular disorder

研究者

发起方
Coombe Women and Infants University Hospital

相似试验